EGFR

Advertisement
Charlotte RobinsonChronic Kidney Disease | June 17, 2025
Variability in eGFR over time is associated with risks of cardiovascular and kidney outcomes and mortality in those with CKD.
Charlotte RobinsonERA Congress 2025 | June 11, 2025
Pegcetacoplan reduced proteinuria and stabilized eGFR in adolescent patients with C3G or primary IC-MPGN.
Charlotte RobinsonERA Congress 2025 | June 11, 2025
Treatment effects of nefecon were consistent independent of baseline eGFR among patients with IgAN.
Victoria SochaChronic Kidney Disease | June 2, 2025
Finerenone had kidney and cardiovascular benefits for patients with CKD even after an acute eGFR change occurred.
Meghan Sise, MDNKF Spring Clinical Meetings 2025 | April 24, 2025
Joel Topf spoke to onconephrologist Meghan Sise about her carboplatin dosing research at SCM25.
Victoria SochaNKF Spring Clinical Meetings 2025 | June 13, 2025
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | June 13, 2025
The National Kidney Foundation (NKF) announced the Spring Clinical Meetings 2025 (SCM25) Outstanding Poster honorees.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 7, 2025
Research explored kidney outcomes among young patients receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | June 13, 2025
Dosing calculations for carboplatin made using Cockcroft-Gault creatinine clearance may result in excess dosing.
Charlotte RobinsonNKF Spring Clinical Meetings 2025 | June 13, 2025
Impaired kidney function was the primary predictor of hemorrhage among patients treated with anticoagulant apixaban.
Charlotte RobinsonChronic Kidney Disease | June 13, 2025
A study compared stroke and dementia risk between race-free and previous eGFR equations.
Charlotte RobinsonWCN 2025 | June 13, 2025
Zigakibart for treatment of IgA nephropathy (IgAN) was well tolerated, reduced proteinuria, and stabilized eGFR at 76 weeks.
Charlotte RobinsonChronic Kidney Disease | June 13, 2025
What is the effect on CKD prevalence of adopting the race-free equation for eGFR in a US military population?
Charlotte RobinsonDiabetes and Hypertension | June 13, 2025
Researchers tried to determine whether eGFR slope is a predictor of type 2 diabetes complications.
Charlotte RobinsonNephrology Times | June 13, 2025
When assessing GFR, stratifying only by mGFR or eGFR to determine biases can lead to erroneous conclusions.
Victoria SochaNKF Spring Clinical Meetings 2023 | February 5, 2024
Patients with advanced chronic kidney disease (CKD) commonly experience gout, a condition associated with CKD ...
Victoria SochaNephrology Times | February 5, 2024
Overall, the prevalence of chronic kidney disease (CKD) among adults in the United States is approximately 15%. In ...
Victoria SochaASN Kidney Week 2022 | February 5, 2024
Decline in renal function is associated with hyperuricemia and gout. Independent of chronic kidney disease (CKD) stage, ...
Victoria SochaKidney Transplantation | February 5, 2024
Estimated glomerular filtration rate (eGFR) is the best marker of allograft function and is a predictor of  allograft ...
Victoria SochaKidney Transplantation | February 5, 2024
Pregnancy following kidney transplantation has become more common in recent years. The voluntary Transplant Pregnancy ...
Advertisement